Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug.
Their research, published today in the journal Molecular Pharmaceutics, shows how a new anti-heroin formulation that is safe in animal models remains stable at room temperature for at least 30 days. As a result, the vaccine is close to being ready for human testing.
“The heroin vaccine is one step closer to clinical evaluation,” says Candy S. Hwang, PhD, first author of the study and a research associate at TSRI.
According to the National Institute on Drug Abuse, 15,446 Americans died from heroin overdose between 2000 and 2016, and the mortality rates are increasing. Heroin abuse has been further fueled by a rise in prescription opioid abuse—studies show that opioid pain reliever users are 40 times more likely to abuse heroin.
The first formulation of the heroin vaccine was developed in 2013 by a team led by Kim D. Janda, PhD, the Ely R. Callaway Jr. Professor of Chemistry and member of the Skaggs Institute for Chemical Biology at TSRI. It has been shown to be effective—and safe—in both mouse and non-human primate models.
The vaccine works by training the immune system antibodies to recognize and bind to heroin molecules, blocking the drug from reaching the brain to cause a “high.” Researchers believe that blocking the high of heroin will help eliminate the motivation for many recovering addicts to relapse into drug use.
The heroin molecule does not naturally prompt an antibody response, so researchers attach it to a carrier protein that alerts the immune system to start making antibodies. Scientists also add an ingredient called an adjuvant to the vaccine, which boosts the immune response and makes the vaccine more effective.
Hwang says, “Our goal was to prepare a vaccine that could be advanced to clinical trials. As such, we were looking for the best combination of ‘hapten’ (the heroin molecule), carrier protein and adjuvant to keep the vaccine both stable for transport and storage but still efficacious.”
For the new study, the researchers investigated how 20 different carrier protein/adjuvant combinations worked, including shelf stability based on temperature and storage time and whether the formulation was a liquid or powder.
Their experiments in rodent models showed that the best vaccine formulation contained a carrier protein called tetanus toxoid (TT) and adjuvants called alum and CpG ODN. The discovery that alum worked best as an adjuvant was especially significant since alum is one of the few adjuvants used in vaccines already approved by the U.S. Food and Drug Administration. The researchers also found that there was no difference in how well it worked between the liquid and powder versions of this formulation.
Hwang notes that the best vaccine formulation showed protection against lethal doses of heroin. This is particularly important as many heroin addicts have succumb to overdose and death during their attempts to quit the drug.
With this new study, the researchers have shown that the vaccine is safe and effective in animal models, stable under clinical conditions and reliant on an already-approved adjuvant. The next step is to find a producer to make the vaccine on a large scale.
“We believe that a heroin vaccine would be tremendously beneficial for people who have a heroin substance use disorder but have found difficulty in trying to quit,” says Hwang.
Learn more: Heroin vaccine blocks lethal overdose
The Latest on: Heroin vaccine
Uganda: Government Probes Hospitals Over Fake Hepatitis B Vaccines
on March 15, 2018 at 12:47 am
KAMPALA/MBARARA — The government is set to investigate health facilities that the National Drug Authority (NDA) said it found with stocks of fake Hepatitis B vaccines. Dr Medard Bitekyerezo, the NDA board chairman, said their inquiries will focus on ... […]
Pakistan Is Racing to Combat the World’s First Extensively Drug-Resistant Typhoid Outbreak
on March 14, 2018 at 4:28 am
Mariam’s infection was designated “extensively drug resistant,” or XDR—meaning it would only ... campaign to battle the spread of the mutated strain. A new typhoid vaccine, produced in neighboring India, was approved by the World Health ... […]
Participants in rogue herpes vaccine research take legal action
on March 13, 2018 at 6:49 pm
SIU professor William Halford, who died in June, had injected Americans with his experimental herpes vaccine in St. Kitts and Nevis in 2016 and in Illinois hotel rooms in 2013 without safety oversight that is routinely performed by the Food and Drug ... […]
Silence From FDA After 'Vaccines Cause Autism' Claims
on March 11, 2018 at 10:19 am
Vaccines do not cause autism and the U.S. Food and Drug Administration did not make any new statement this week about the long-debunked claim. Autism was listed as one of many "adverse events" on the 2005 label of Sanofi Pasteur's Tripedia childhood ... […]
Flu experts call for new vaccines, drugs and diagnostics
on March 8, 2018 at 1:08 pm
Acknowledging the vaccine's less-than-optimal effectiveness ... Gottlieb noted that the Osaka-based drug company, Shionogi & Co. Ltd., has said publicly that it will submit an application to the FDA this year. 'Alternative approaches' Bright noted that ... […]
A vaccine for prostate cancer? British scientists design a breakthrough drug which boosts the immune system's ability to track down and kill deadly cells as soon as they appear
on March 5, 2018 at 3:06 pm
Experts have designed a vaccine that boosts the immune system’s ability to track down and kill the cancer cells as soon as they start to appear. The research is at an early stage, but scientists from Queen’s University Belfast believe their findings ... […]
Morning Break: Flu Vaccine Hype; Suburban Rabies Scare; Jet Lag Drug Win
on March 5, 2018 at 7:02 am
Note that some links may require subscriptions. The FDA warned consumers about "fraudulent and unapproved" products for treating or preventing flu infections. Helen Branswell at STAT News cuts through the hype on universal flu vaccines: "not really there yet. […]
Discover the veterinary/animal vaccines market analysis and forecast 2017-2024
on March 4, 2018 at 11:33 pm
... animal health which evades transmission of diseases from animals to humans.Veterinary vaccines are the most productive product segment of focus for veterinary drug manufacturers.The vaccines can be administered intramuscularly (into the muscle)or ... […]
via Google News and Bing News